Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
385.00    -2.00 (-0.52%)
Bid:
385.00
Ask:
387.00
Spread: 2.00 (0.519%)
Market Cap: £1.74b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Acquisition

19 Dec 2007 14:25

HG Capital Trust PLC19 December 2007 The following is the text of a press release issued by HgCapital, which managesthe investment portfolio of HgCapital Trust plc alongside those of otherinstitutional clients. The Trust, which is a listed investment trust givinginvestors the opportunity to participate in all of HgCapital's investments, willinvest approximately €16.7million (£12m) in Casa Reha. HgCapital acquires Casa Reha from Advent International London, 19th December 2007: HgCapital, the European sector-focused privateequity investor, has acquired Casa Reha, one of the leading German privatenursing home groups. The transaction is subject to regulatory approval. Thecompany has been acquired from Advent International and management, both ofwhich are re-investing in the business. The value of the transaction wasundisclosed. Casa Reha, founded in 1995 by Covenant Care International is headquartered inOberursel, Germany. The first nursing home was opened in 1996. Today, Casa Rehais the country's fifth largest nursing home operator, with a nationwideportfolio of 48 homes providing around 7,000 beds. Contacts: HgCapitalPhilipp Schwalber Tel: +44 (0)20 7089 7888 Hering-Schuppener (German Press)Georg Jakobs/Dennis Bader Tel: +49 (69) 92187476 Maitland (UK Press)Peter Ogden Tel: +44 (0)20 7379 5151 Advent InternationalClaudia Werth Tel: +49 (69) 92037 114 About HgCapitalHgCapital is a private-equity investor in the European mid-market. We focus oninvestments with an enterprise value in the range of €75-750 million. Ourbusiness model combines sector specialisation with dedicated, pro-active supportto our portfolio companies as well as the corresponding management expertiseacross all phases of the investment process. HgCapital manages more than €2.7billion for some of the world's leading institutional and private investors. Ourgoal is to achieve outstanding results for our investors, management team andintermediaries. Further information on HgCapital can be found atwww.hgcapital.com. HgCapital's recent transactions in the healthcare sector include: • May 2007: sale of DocMorris to Celesio • July 2006: sale of Castlebeck to Castle Holdings Limited for £255m • June 2006: IPO of ClinPhone - market capitalisation of £94 million • June 2006: Sale of Pharma Bio-Research BV (PBR) to PRA International for £58 million • April 2006: £322 million MBO of Paragon Healthcare • September 2005: Sale of Tunstall for £220 million About Advent InternationalFounded in 1984, Advent International is one of the world's leading globalprivate equity firms, with offices in 15 countries on four continents. A drivingforce in international private equity for more than two decades, Advent hasbuilt an unparalleled global platform of over 100 investment professionalsacross Western and Central Europe, North America, Latin America and Asia. Thefirm focuses on cross-border, strategic restructuring and growth opportunitiesin five core sectors, employing a highly focused ownership approach to driveearnings improvements in portfolio companies. Since inception, Advent has raised£6 billion in private equity capital and completed more than 200 buyout andprivate equity transactions valued at over £15 billion in 35 countries. For moreinformation, visit www.adventinternational.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Sep 20212:46 pmRNSHolding(s) in Company
28th Sep 20215:17 pmRNSIssue of Equity
28th Sep 202111:00 amRNSBrightPay and Relate Software join forces
23rd Sep 20215:09 pmRNSIssue of Equity
21st Sep 20215:40 pmRNSIssue of Equity
20th Sep 20215:18 pmRNSIssue of Equity
17th Sep 20215:21 pmRNSIssue of Equity
16th Sep 20215:15 pmRNSIssue of Equity
15th Sep 20215:15 pmRNSIssue of Equity
15th Sep 202110:00 amRNSHg announces the sale of Achilles
14th Sep 20215:05 pmRNSIssue of Equity
14th Sep 20217:00 amRNSHg invests in HHAeXchange
13th Sep 20215:06 pmRNSIssue of Equity
10th Sep 20215:04 pmRNSIssue of Equity
9th Sep 20215:09 pmRNSIssue of Equity
8th Sep 20215:28 pmRNSIssue of Equity
7th Sep 20215:36 pmRNSIssue of Equity
26th Aug 20219:00 amRNSSerrala secures strategic investment from Hg
25th Aug 20214:00 pmRNSHg invests in Riskalyze
20th Aug 20213:00 pmRNSHg invests in Managed Markets Insight & Technology
13th Jul 20217:00 amRNSinsightsoftware attracts c.$1bn investment from Hg
1st Jul 202110:43 amRNSTotal Voting Rights
28th Jun 20218:00 amRNSHg agrees the sale of Allocate to RLDatix
25th Jun 20215:50 pmRNSIssue of Equity
24th Jun 20215:26 pmRNSIssue of Equity
23rd Jun 20215:17 pmRNSIssue of Equity
22nd Jun 20215:14 pmRNSIssue of Equity
21st Jun 20215:44 pmRNSIssue of Equity
18th Jun 20215:35 pmRNSIssue of Equity
17th Jun 20215:48 pmRNSIssue of Equity
14th Jun 20215:22 pmRNSIssue of Equity
11th Jun 20215:21 pmRNSIssue of Equity
10th Jun 20215:58 pmRNSDirector/PDMR Shareholding
10th Jun 20215:50 pmRNSIssue of Equity
10th Jun 20218:00 amRNSEdison issues update on HgCapital Trust (HGT)
9th Jun 20215:45 pmRNSIssue of Equity
8th Jun 20215:34 pmRNSIssue of Equity
7th Jun 20215:26 pmRNSIssue of Equity
4th Jun 20215:22 pmRNSIssue of Equity
3rd Jun 20215:19 pmRNSIssue of Equity
1st Jun 20215:48 pmRNSIssue of Equity
1st Jun 202110:46 amRNSTotal Voting Rights
28th May 20215:07 pmRNSIssue of Equity
27th May 20215:34 pmRNSIssue of Equity
25th May 20214:58 pmRNSIssue of Equity
24th May 20215:16 pmRNSIssue of Equity
17th May 20215:26 pmRNSIssue of Equity
14th May 20215:11 pmRNSIssue of Equity
13th May 20214:38 pmRNSDirector/PDMR Shareholding
13th May 20213:37 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.